newsfilter
← Latest News
GlobeNewswire·

Cytek Biosciences Announces Preliminary Fourth Quarter and Full Year 2025 Revenue Results

FREMONT, Calif., Jan. 12, 2026 (GLOBE NEWSWIRE) -- Cytek Biosciences, Inc. (NASDAQ:CTKB), a leading cell analysis solutions company, today announced preliminary, unaudited revenue results for the fourth quarter and